Demographic and epidemiologic drivers of global cardiovascular mortality
Open accessAbstract
BACKGROUND: Global deaths from cardiovascular disease are increasing as a result of population growth, the aging of populations, and epidemiologic changes in disease. Disentangling the effects of these three drivers on trends in mortality is important for planning the future of the health care system and benchmarking progress toward the reduction of cardiovascular disease. METHODS: We used mortality data from the Global Burden of Disease Study 2013, which includes data on 188 countries grouped into 21 world regions. We developed three counterfactual scenarios to represent the principal drivers of change in cardiovascular deaths (population growth alone, population growth and aging, and epidemiologic changes in disease) from 1990 to 2013. Secular trends and correlations with changes in national income were examined. RESULTS: Global deaths from cardiovascular disease increased by 41% between 1990 and 2013 despite a 39% decrease in age-specific death rates; this increase was driven by a 55% increase in mortality due to the aging of populations and a 25% increase due to population growth. The relative contributions of these drivers varied by region; only in Central Europe and Western Europe did the annual number of deaths from cardiovascular disease actually decline. Change in gross domestic product per capita was correlated with change in age-specific death rates only among upper-middle income countries, and this correlation was weak; there was no significant correlation elsewhere. CONCLUSIONS: The aging and growth of the population resulted in an increase in global cardiovascular deaths between 1990 and 2013, despite a decrease in age-specific death rates in most regions. Only Central and Western Europe had gains in cardiovascular health that were sufficient to offset these demographic forces. (Funded by the Bill and Melinda Gates Foundation and others.).
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
0 of 5 cited sources checked · 0 supported · 0 flagged
- Findingown data
For ischemic heart disease, global deaths increased by 41.7% from 1990 to 2013.
“For the most common cause of cardiovascular death, ischemic heart disease, the number of deaths increased by an estimated 41.7% from 1990 to 2013.”
Quote in the paperSubstantial claim - Findingown data
Global age-specific death rates for hemorrhagic stroke declined by more than 55% because of epidemiologic changes.
“Even larger declines (more than 55%) were seen as a result of epidemiologic changes in the risk of hemorrhagic stroke.”
Quote in the paperNot a substantial claim - Findingown data
Epidemiologic change led to an increase in cardiovascular deaths in only one region, western sub-Saharan Africa.
“According to our estimates, epidemiologic change led to an increase in cardiovascular deaths in only one region of the world (western sub-Saharan Africa).”
Quote in the paperNot a substantial claim - Findingown data
The most common epidemiologic profile among specific cardiovascular causes was increases due to population growth and aging together with declines in age-specific death rates.
“The combination of increases in the number of deaths due to population growth and population aging and declines in age-specific death rates represented the most common epidemiologic profile among the specific cardiovascular causes of death (Table 1).”
Quote in the paperSubstantial claim - Findingown data
Population growth contributed a 23.6% increase in global ischemic heart disease deaths from 1990 to 2013.
“whereas population growth contributed to an estimated 23.6% increase.”
Quote in the paperSubstantial claim
- Findingown data
Rheumatic heart disease was the only cardiovascular condition with fewer total global deaths in 2013 than in 1990.
“Rheumatic heart disease was the only cardiovascular condition for which there were fewer total deaths globally in 2013 than in 1990.”
Quote in the paperNot a substantial claim - Findingown data
Ischemic heart disease was the largest contributor to the increase in global cardiovascular deaths, contributing 2.4 million of the overall increase of 5.0 million deaths.
“Ischemic heart disease was the largest contributor to the increase in the number of cardiovascular deaths (2.4 million of the overall increase of 5.0 million cardiovascular deaths)”
Quote in the paperNot a substantial claim - Findingown data
Western Europe had an estimated 12.8% decline in cardiovascular deaths from 1990 to 2013.
“Central Europe and Western Europe, which had declines of an estimated 5.2% and 12.8%, respectively.”
Quote in the paperNot a substantial claim - Findingown data
East Asia had more than 1.2 million additional cardiovascular deaths in 2013 than in 1990, representing a 47.2% increase.
“East Asia reported more than 1.2 million additional deaths in 2013, representing a 47.2% increase from 1990.”
Quote in the paperNot a substantial claim - Findingown data
Only Central Europe and Western Europe had a significant decline in annual cardiovascular deaths between 1990 and 2013.
“only in Central Europe and Western Europe did the annual number of deaths from cardiovascular disease actually decline.”
- Also stated in: § CARDIOVASCULAR DEATHS ACCORDING TO REGION · plain
“The only regions with a significant decrease in cardiovascular deaths were Central Europe and Western Europe, which had declines of an estimated 5.2% and 12.8%, respectively.”
Quote in the paperSubstantial claim - Also stated in: § CARDIOVASCULAR DEATHS ACCORDING TO REGION · plain
- Findingnone given
The directional trends for rheumatic heart disease were similar with respect to population growth, aging, and age-specific death rates.
“The directional trends for rheumatic heart disease were similar with respect to population growth, aging, and age-specific death rates.”
Quote in the paperNot a substantial claim - Findingown data
Large reductions in the age-specific risk of death from ischemic heart disease led to almost 2 million fewer deaths than would have been expected had death rates remained unchanged from 1990.
“On the basis of these estimates, large reductions in the age-specific risk of death from ischemic heart disease have led to almost 2 million fewer deaths than would have been expected had death rates remained unchanged from 1990.”
Quote in the paperSubstantial claim - Findingown data
Population aging contributed a 52.5% increase in global ischemic heart disease deaths from 1990 to 2013.
“Population aging contributed to an estimated 52.5% increase in these deaths”
Quote in the paperSubstantial claim - Findingown data
Global age-specific death rates for ischemic heart disease declined by 34.4% because of epidemiologic changes.
“despite an estimated decline of 34.4% (95% uncertainty interval, 27.1 to 40.4) owing to global epidemiologic changes in ischemic heart disease.”
Quote in the paperSubstantial claim - Findingown data
In the high-income Asia-Pacific region, the net decrease in age- and sex-specific cardiovascular death rates was 121% from 1990 to 2013.
“We report this difference as a net decrease of 121% in the age- and sex-specific death rates (422,872 fewer cardiovascular deaths than expected divided by 349,153 cardiovascular deaths observed in 1990).”
Quote in the paperNot a substantial claim - Findingown data
There was no significant correlation between change in GDP per capita and change in age-specific cardiovascular death rates in low-income, lower-middle-income, or high-income countries.
“there was no significant correlation elsewhere.”
- Also stated in: § CARDIOVASCULAR DEATHS AND NATIONAL INCOME PER CAPITA · plain
“Pearson’s correlation coefficients for the four levels of income were as follows: low income, r=0.20, P=0.24; lower-middle income, r=−0.08, P=0.60; upper-middle income, r=−0.33, P=0.02; and high income, r= −0.19, P= 0.18.”
Quote in the paperSubstantial claim - Also stated in: § CARDIOVASCULAR DEATHS AND NATIONAL INCOME PER CAPITA · plain
- Findingown data
The decline due to epidemiologic changes for rheumatic heart disease was more than 100%.
“However, the magnitude of the decline due to epidemiologic changes — a decrease of more than 100% — led to an estimated decline in the number of deaths of 26.5% (95% uncertainty interval, 17.2 to 33.6).”
Quote in the paperNot a substantial claim - Findingreasoning
Global deaths from rheumatic heart disease declined by 26.5% between 1990 and 2013.
“led to an estimated decline in the number of deaths of 26.5% (95% uncertainty interval, 17.2 to 33.6).”
Quote in the paperNot a substantial claim - Findingown data
The relative contributions of population growth, aging, and epidemiologic change to cardiovascular deaths varied by region.
“The relative contributions of these drivers varied by region”
- Also stated in: § CARDIOVASCULAR DEATHS ACCORDING TO REGION · plain
“The percentage change from 1990 to 2013 in the total number of deaths from all cardiovascular causes varied significantly by region (Fig. 2).”
Quote in the paperSubstantial claim - Also stated in: § CARDIOVASCULAR DEATHS ACCORDING TO REGION · plain
- Findingown data
Population aging contributed a 55% increase in global cardiovascular deaths from 1990 to 2013.
“a 55% increase in mortality due to the aging of populations”
- Also stated in: § GLOBAL DEATHS DUE TO CARDIOVASCULAR DISEASES · plain
“This increase was driven by the change in the number of deaths attributed to population aging (55% increase from 1990; 95% uncertainty interval, 54.5 to 55.4)”
Quote in the paperSubstantial claim - Also stated in: § GLOBAL DEATHS DUE TO CARDIOVASCULAR DISEASES · plain
- Findingown data
Population growth contributed a 25.1% increase in global cardiovascular deaths from 1990 to 2013.
“a 25% increase due to population growth”
- Also stated in: § GLOBAL DEATHS DUE TO CARDIOVASCULAR DISEASES · plain
“and population growth (25.1% increase from 1990; 95% uncertainty interval, 24.7 to 25.5).”
Quote in the paperSubstantial claim - Also stated in: § GLOBAL DEATHS DUE TO CARDIOVASCULAR DISEASES · plain
- Findingown data
Global deaths from cardiovascular disease rose by 40.8% between 1990 and 2013.
“Global deaths from cardiovascular disease increased by 41% between 1990 and 2013 despite a 39% decrease in age-specific death rates; this increase was driven by a 55% increase in mortality due to the aging of populations and a 25% increase due to population growth.”
- Also stated in: § GLOBAL DEATHS DUE TO CARDIOVASCULAR DISEASES · plain
“In 2013, the number of people who died from cardiovascular disease was more than 17.3 million (95% uncertainty interval, 16.5 to 18.1), representing an increase from 1990 of 40.8% (95% uncertainty interval, 36.2 to 46.4), despite a decrease in deaths attributable to epidemiologic changes of 39.3% (95% uncertainty interval, 33.6 to 44.1) (Table 1).”
Quote in the paperSubstantial claim - Also stated in: § GLOBAL DEATHS DUE TO CARDIOVASCULAR DISEASES · plain
- Findingown data
The absolute numbers of deaths from atrial fibrillation or flutter and peripheral vascular disease remained relatively low compared with ischemic heart disease and stroke.
“However, the absolute numbers of deaths ascribed to these conditions remained relatively low as compared with those ascribed to ischemic heart disease and stroke.”
Quote in the paperNot a substantial claim - Findingown data
Central Europe had an estimated 5.2% decline in cardiovascular deaths from 1990 to 2013.
“Central Europe and Western Europe, which had declines of an estimated 5.2% and 12.8%, respectively.”
Quote in the paperNot a substantial claim - Interpretationreasoning
In regions where the decrease due to epidemiologic change was relatively small (category 1), the combined effect of population growth and aging poses the greatest threat.
“However, in regions where this decrease was relatively small (i.e., regions in category 1), the combined effect of population growth and aging poses the greatest threat.”
Quote in the paperSubstantial claim - Study design and conductreasoning
The estimates of global burden of disease may not account for the actual variation in cardiovascular mortality among some countries.
“As a result, our estimates of the global burden of disease may not account for the actual variation in cardiovascular mortality among some countries.”
Quote in the paperNot a substantial claim - Interpretationnone given
North Africa and the Middle East offset a similar trend in population growth and aging with a significant decline in age-specific death rates.
“North Africa and the Middle East offset a similar trend in population growth and aging with a significant decline in age-specific death rates.”
Quote in the paperSubstantial claim - Interpretationown data
Increases in GDP per capita do not correlate well with declines in age-specific cardiovascular risk.
“We also show that increases in GDP per capita do not correlate well with declines in age-specific risk.”
Quote in the paperSubstantial claim - Interpretationreasoning
Smaller relative gains in health, paired with a lesser degree of population aging, account for the decline in total cardiovascular deaths in Western Europe.
“Smaller relative gains in health, paired with a lesser degree of population aging, account for the decline in total cardiovascular deaths in Western Europe.”
Quote in the paperSubstantial claim - Interpretationreasoning
The combined effects of population growth, population aging, and changing age-specific death rates underlie the disparate trends in total cardiovascular deaths observed across world regions.
“The combined effects of population growth, population aging, and changing age-specific death rates underlie the disparate trends in total cardiovascular deaths observed across world regions.”
Quote in the paperSubstantial claim - Study design and conductreasoning
Attributing each death to a single underlying cause leads to some degree of misclassification bias.
“Our standard approach of attributing each death to a single underlying cause is intentionally defined according to GBD 2013 methods for the purpose of comparability and clarity. However, there will be some degree of misclassification bias.”
Quote in the paperNot a substantial claim - Interpretationown data
In the high-income Asia-Pacific region, the potential for an increase in cardiovascular mortality caused by a rapidly aging population appears to have been limited by the world's largest decline in age-specific rates of cardiovascular death.
“In the high-income Asia–Pacific region, the potential for an increase in cardiovascular mortality caused by a rapidly aging population appears to have been limited by the world’s largest decline in age-specific rates of cardiovascular death.”
Quote in the paperSubstantial claim - Interpretationown data
Without the effect of population growth and aging, epidemiologic change would have led to a reduction in the numbers of cardiovascular deaths in most regions.
“Our analysis shows that without the effect of population growth and aging, epidemiologic change would have led to a reduction in the numbers of cardiovascular deaths in most regions.”
Quote in the paperSubstantial claim
- May combine two claims. 10
- The quote only partly states this claim. 1
- Classified as probably not a substantial claim. 8
May combine two claims.
Findingown dataChange in GDP per capita was correlated with change in age-specific cardiovascular death rates only among upper-middle-income countries, and the correlation was weak.
“Change in gross domestic product per capita was correlated with change in age-specific death rates only among upper-middle income countries, and this correlation was weak; there was no significant correlation elsewhere.”
- Also stated in: § CARDIOVASCULAR DEATHS AND NATIONAL INCOME PER CAPITA · plain
“the two variables had a significant correlation only within the category of upper-middle income.”
Quote in the paperSubstantial claim- Also stated in: § CARDIOVASCULAR DEATHS AND NATIONAL INCOME PER CAPITA · plain
May combine two claims.
FindingreasoningSouthern Latin America, Australasia, and high-income North America had no detectable change in cardiovascular deaths from 1990 to 2013.
“Southern Latin America, Australasia, and high-income North America had no detectable change in the number of deaths from 1990 to 2013 (as indicated by an uncertainty interval crossing 0) because population aging and growth balanced out declines in age-specific death rates.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataDeaths from atrial fibrillation or flutter and peripheral vascular disease increased dramatically between 1990 and 2013, driven by population growth, aging, and increases in age- and sex-specific death rates.
“Atrial fibrillation or flutter and peripheral vascular disease are notable exceptions to the demographic and epidemiologic pattern for cardiovascular disease. Deaths from each of these conditions increased dramatically between 1990 and 2013, driven not only by population growth and aging but also by increases in age- and sex-specific death rates.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataSouth Asia had the largest absolute increase in cardiovascular deaths, with more than 1.7 million additional deaths in 2013 than in 1990, representing a 97.4% increase.
“In absolute terms, South Asia had the largest estimated increase in deaths from cardiovascular disease, reporting more than 1.7 million more deaths in 2013 than in 1990. This change represents an increase of 97.4% (95% uncertainty interval, 72 to 126.1).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataIn the high-income Asia-Pacific region, there were 349,153 cardiovascular deaths in 1990 and 487,170 in 2013, which was less than the 910,042 expected if 1990 death rates had remained constant given 2013 population size and age structure.
“For example, there were 349,153 cardiovascular deaths in the high-income Asia–Pacific region in 1990. In 2013, there were 487,170 cardiovascular deaths, which is less than the 910,042 that would have been expected if 1990 death rates had remained constant, given the population size and the age structure in that region in 2013.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataMost countries had an increase in income per capita and a decline in the number of cardiovascular deaths due to epidemiologic change.
“Most countries had an increase in income per capita and a decline in the number of cardiovascular deaths due to epidemiologic change.”
Quote in the paperNot a substantial claimThe quote only partly states this claim.
Findingown dataGlobal age-specific cardiovascular death rates fell by 39.3% between 1990 and 2013 because of epidemiologic changes.
“despite a 39% decrease in age-specific death rates”
- Also stated in: § GLOBAL DEATHS DUE TO CARDIOVASCULAR DISEASES · plain
“despite a decrease in deaths attributable to epidemiologic changes of 39.3% (95% uncertainty interval, 33.6 to 44.1)”
Quote in the paperSubstantial claim- Also stated in: § GLOBAL DEATHS DUE TO CARDIOVASCULAR DISEASES · plain
May combine two claims.
Findingown dataThe pattern of increases due to population growth and aging with declines in age-specific death rates was present for ischemic heart disease, ischemic stroke, hemorrhagic and other nonischemic stroke, hypertensive heart disease, cardiomyopathy, myocarditis, aortic aneurysm, and endocarditis.
“This pattern was also present in trends for ischemic heart disease, ischemic stroke, hemorrhagic and other nonischemic causes of stroke, hypertensive heart disease, cardiomyopathy, myocarditis, aortic aneurysm, and endocarditis.”
Quote in the paperSubstantial claimMay combine two claims.
InterpretationcitationReductions in cardiovascular deaths due to epidemiologic change in high-income countries are probably due to decreased exposure to tobacco smoking, improvements in diet, and improved treatment of cardiovascular disease and cardio-metabolic risk factors.
“These changes are probably due to the combined effect of birth cohorts’ decreased exposure to tobacco smoking, improvements in diet, and improved treatment of cardiovascular disease and cardio-metabolic risk factors targeting the prevention of cardiovascular disease, and improved treatment of cardiovascular disease.10”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [10] source
Not checked in the free run.
May combine two claims.
Interpretationown dataSouth Asia had a dramatic rise in cardiovascular deaths due to population growth and aging without a significant decline in cardiovascular deaths due to epidemiologic change.
“In contrast, South Asia had a dramatic rise in cardiovascular deaths due to population growth and aging without a significant decline in cardiovascular deaths due to epidemiologic change.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenThe rigorous out-of-sample predictive validity testing used in GBD 2013 is cause for some confidence in the estimates.
“However, the rigorous out-of-sample predictive validity testing used in GBD 2013 is cause for some confidence.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationThe classic model of epidemiologic transition does not fully reflect the heterogeneity of the burden of cardiovascular disease across countries.
“As they have noted, the classic model of “epidemiologic transition” does not fully reflect the heterogeneity of the burden of cardiovascular disease across countries.”
Quote in the paperNot a substantial claim0 of 2 sources checkedProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationA deterministic health policy model indicated that 40 to 55% of the decline in coronary heart disease in high-income countries can be attributed to the effects of medical and surgical treatments.
“A deterministic health policy model indicated that 40 to 55% of the decline in coronary heart disease in high-income countries can be attributed to the effects of medical and surgical treatments.12”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [12] source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing), S4 (based). May combine two claims.
Interpretationnone givenPatterns of disease burden vary within countries, so any summary at the level of a region or country may mask significant disparities within that area.
“Finally, we recognize that patterns of disease burden vary not just between but also within countries. Any summary provided at the level of a region or country may mask significant disparities within that area.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductcitationCalculations made with the traditional Shapley method and other econometric methods may produce different results from the decomposition procedure used.
“However, calculations made with the traditional Shapley method and other methods used in econometrics may produce different results.6”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [6] source
Not checked in the free run.
Classified as probably not a substantial claim.
Study design and conductnone givenCause-specific mortality data are lacking or of limited quality in some countries.
“First, cause-specific mortality data are lacking or of limited quality in some countries.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing), S4 (based).
Study design and conductnone givenThe number of deaths resulting from rheumatic heart disease may not be completely captured by vital records in regions in which the condition is endemic.
“Similarly, the number of deaths resulting from rheumatic heart disease may not be completely captured by vital records in regions in which the condition is endemic.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing), S4 (based).
InterpretationreasoningThe remarkable increase in the age-specific rate of death from atrial fibrillation probably reflects increases in the screening, recognition, and attribution of death to atrial fibrillation in addition to changes in disease epidemiology.
“Furthermore, the remarkable increase in the age-specific rate of death from atrial fibrillation probably reflects increases in the screening, recognition, and attribution of death to atrial fibrillation in addition to changes in disease epidemiology.”
Quote in the paperNot a substantial claim
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Population ageing adds to the absolute number of cardiovascular disease events.
“Ageing of the population also contributes to increasing the absolute number of CVD events. 17”
From 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias (2016) · cites this paper as [17]
Population ageing contributes to increasing the absolute number of cardiovascular disease events.
“Ageing of the population also contributes to increasing the absolute number of CVD events.17”
From 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias (2016) · cites this paper as [17]
Cites
Lozano, R., Naghavi, M., Foreman, K., Lim, S., Shibuya, K., Aboyans, V., Abraham, J., Adair, T., Aggarwal, R., Ahn, S. Y., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61728-0 · Cited by 14,070 · see citing works
Self-citationExplaining the decrease in U.S. deaths from coronary disease, 1980–2000
Ford, E. S., Ajani, U. A., Croft, J. B., Critchley, J. A., Labarthe, D. R., Kottke, T. E., Giles, W. H., & Capewell, S. (2007) · New England Journal of Medicine · doi:10.1056/nejmsa053935 · Cited by 2,757 · see citing works
Universal Definition of Myocardial Infarction: Clinical Insights
Paiva, L., Providencia, R. A., Barra, S., Dinis, P., Faustino, C., & Gonçalves, L. M. M. (2015) · Cardiology · doi:10.1159/000371739 · Cited by 2,513 · see citing works
Smoking prevalence and cigarette consumption in 187 countries, 1980-2012
Ng, M., Freeman, M. K., Fleming, T. D., Robinson, M., Dwyer-Lindgren, L., Thomson, B., Wollum, A., Sanman, E., Wulf, S., Lopez, A. D., et al. (2014) · JAMA · doi:10.1001/jama.2013.284692 · Cited by 1,576 · see citing works
Self-citationEmerging Epidemic of Cardiovascular Disease in Developing Countries
Reddy, K. S., & Yusuf, S. (1998) · Circulation · doi:10.1161/01.cir.97.6.596 · Cited by 1,206 · see citing works
Decomposition procedures for distributional analysis: a unified framework based on the Shapley value
Shorrocks, A. F. (2013) · The Journal of Economic Inequality · doi:10.1007/s10888-011-9214-z · Cited by 1,190 · see citing works
Yusuf, S., Reddy, S., Ôunpuu, S., & Anand, S. (2001) · Circulation · doi:10.1161/hc4701.099488 · Cited by 1,141 · see citing works
Ezzati, M., Hoorn, S. V., Lawes, C. M. M., Leach, R. J., James, W. P. T., López, A. D., Rodgers, A., & Murray, C. J. L. (2005) · PLoS Medicine · doi:10.1371/journal.pmed.0020133 · Cited by 626 · see citing works
Self-citationModeling causes of death: an integrated approach using CODEm
Foreman, K. J., Lozano, R., Lopez, A. D., & Murray, C. J. (2012) · Population Health Metrics · doi:10.1186/1478-7954-10-1 · Cited by 564 · see citing works
Self-citationAlgorithms for enhancing public health utility of national causes-of-death data
Naghavi, M., Makela, S., Foreman, K., O'Brien, J., Pourmalek, F., & Lozano, R. (2010) · Population Health Metrics · doi:10.1186/1478-7954-8-9 · Cited by 440 · see citing works
Self-citationO'Flaherty, M., Buchan, I., & Capewell, S. (2013) · Heart · doi:10.1136/heartjnl-2012-302300 · Cited by 165 · see citing works
Developing a comprehensive time series of GDP per capita for 210 countries from 1950 to 2015
James, S. L., Gubbins, P., Murray, C. J. L., & Gakidou, E. E. (2012) · Population Health Metrics · doi:10.1186/1478-7954-10-12 · Cited by 116 · see citing works
Self-citationMeasuring progress on NCDs: one goal and five targets
Beaglehole, R., Bonita, R., Horton, R., Ezzati, M., Bhala, N., Amuyunzu-Nyamongo, M., Mwatsama, M., & Reddy, K. S. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61692-4 · Cited by 105 · see citing works
Flagged first, then by citations
Research works printed but not linked: 1
- GBD 2013 Mortality and Causes of Death Collaborators, 2014, Lancet, 385, 117
Cited by
Sorted by citations
McDonagh, T. A., Metra, M., Adamo, M., Gardner, R. S., Baumbach, A., Böhm, M., Burri, H., Butler, J., Čelutkienė, J., Chioncel, O. D., et al. (2021) · PubMed · doi:10.1093/eurheartj/ehab670 · Cited by 19,618 · see citing works
2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure
McDonagh, T. A., Metra, M., Adamo, M., Gardner, R. S., Baumbach, A., Böhm, M., Burri, H., Butler, J., Čelutkienė, J., Chioncel, O., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab368 · Cited by 13,344 · see citing works
Heart Disease and Stroke Statistics—2017 Update: A Report From the American Heart Association
Benjamin, E. J., Blaha, M. J., Chiuve, S. E., Cushman, M., Das, S. R., Deo, R., de Ferranti, S. D., Floyd, J., Fornage, M., Gillespie, C., et al. (2017) · Circulation · doi:10.1161/cir.0000000000000485 · Cited by 12,591 · see citing works
Self-citationGlobal Burden of Cardiovascular Diseases and Risk Factors, 1990–2019
Roth, G. A., Mensah, G. A., Johnson, C. O., Addolorato, G., Ammirati, E., Baddour, L. M., Barengo, N. C., Beaton, A. Z., Benjamin, E. J., Benziger, C. P., et al. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.11.010 · Cited by 11,449 · see citing works
Self-citationMach, F., Baigent, C., Catapano, A. L., Koskinas, K. C., Casula, M., Badimon, L., Chapman, M. J., De Backer, G. G., Delgado, V., Ference, B. A., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehz455 · Cited by 8,961 · see citing works
Heart Disease and Stroke Statistics—2016 Update: A Report From the American Heart Association
Mozaffarian, D., Benjamin, E. J., Go, A. S., Arnett, D. K., Blaha, M. J., Cushman, M., Das, S. R., de Ferranti, S., Després, J.-P., Fullerton, H. J., et al. (2016) · Circulation · doi:10.1161/cir.0000000000000350 · Cited by 6,596 · see citing works
2016 European Guidelines on cardiovascular disease prevention in clinical practice
Piepoli, M. F., Hoes, A. W., Agewall, S., Albus, C., Brotons, C., Catapano, A. L., Cooney, M.-T., Corrà, U., Cosyns, B., Deaton, C., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw106 · Cited by 6,457 · see citing works
Mach, F., Baigent, C., Catapano, A. L., Koskinas, K. C., Casula, M., Badimon, L., Chapman, M. J., De Backer, G. G., Delgado, V., Ference, B. A., et al. (2019) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2019.08.014 · Cited by 4,854 · see citing works
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
Catapano, A. L., Graham, I., De Backer, G., Wiklund, O., Chapman, M. J., Drexel, H., Hoes, A. W., Jennings, C. S., Landmesser, U., Pedersen, T. R., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw272 · Cited by 3,162 · see citing works
2021 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure
Authors/Task Force Members:, McDonagh, T. A., Metra, M., Adamo, M., Gardner, R. S., Baumbach, A., Böhm, M., Burri, H., Butler, J., Čelutkienė, J., et al. (2022) · European Journal of Heart Failure · doi:10.1002/ejhf.2333 · Cited by 2,274 · see citing works
Feigin, V. L., Abate, M. D., Abate, Y. H., ElHafeez, S. A., Abd-Allah, F., Abdelalim, A., Abdelkader, A. F. I., Abdelmasseh, M., Abd-Elsalam, S. M., Abdi, P., et al. (2024) · The Lancet Neurology · doi:10.1016/s1474-4422(24)00369-7 · Cited by 2,060 · see citing works
Self-citationGroenewegen, A., Rutten, F. H., Mosterd, A., & Hoes, A. W. (2020) · European Journal of Heart Failure · doi:10.1002/ejhf.1858 · Cited by 2,043 · see citing works
Epidemiology and aetiology of heart failure
Ziaeian, B., & Fonarow, G. C. (2016) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2016.25 · Cited by 1,888 · see citing works
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
Catapano, A. L., Graham, I., De Backer, G., Wiklund, O., Chapman, M. J., Drexel, H., Hoes, A. W., Jennings, C. S., Landmesser, U., Pedersen, T. R., et al. (2016) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2016.08.018 · Cited by 1,582 · see citing works
Periodontitis and cardiovascular diseases: Consensus report
Sanz, M., Marco del Castillo, A., Jepsen, S., Gonzalez‐Juanatey, J. R., D’Aiuto, F., Bouchard, P., Chapple, I., Dietrich, T., Gotsman, I., Graziani, F., et al. (2020) · Journal of Clinical Periodontology · doi:10.1111/jcpe.13189 · Cited by 1,482 · see citing works
2016 European Guidelines on cardiovascular disease prevention in clinical practice
Authors/Task Force Members, Piepoli, M. F., Hoes, A. W., Agewall, S., Albus, C., Brotons, C., Catapano, A. L., Cooney, M. T., Corrà, U., Cosyns, B., et al. (2016) · European Journal of Preventive Cardiology · doi:10.1177/2047487316653709 · Cited by 1,409 · see citing works
Lear, S. A., Hu, W., Rangarajan, S., Gasevic, D., Leong, D., Iqbal, R., Casanova, A., Swaminathan, S., Anjana, R. M., Kumar, R., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)31634-3 · Cited by 1,331 · see citing works
Update on the Global Burden of Ischemic and Hemorrhagic Stroke in 1990-2013: The GBD 2013 Study
Feigin, V. L., Krishnamurthi, R., Parmar, P. G. K., Norrving, B., Mensah, G. A., Bennett, D., Barker-Collo, S. L., Moran, A. E., Sacco, R. L., Truelsen, T., et al. (2015) · Neuroepidemiology · doi:10.1159/000441085 · Cited by 1,313 · see citing works
Self-citationAge and Age-Related Diseases: Role of Inflammation Triggers and Cytokines
Rea, I. M., Gibson, D. S., McGilligan, V., McNerlan, S. E., Alexander, H. D., & Ross, O. A. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00586 · Cited by 1,267 · see citing works
Reducing the Global Burden of Cardiovascular Disease, Part 1
Joseph, P. G., Leong, D. P., McKee, M., Anand, S. S., Schwalm, J.-D., Teo, K. K., Mente, A., & Yusuf, S. (2017) · Circulation Research · doi:10.1161/circresaha.117.308903 · Cited by 1,089 · see citing works
European Society of Cardiology: Cardiovascular Disease Statistics 2017
Timmis, A., Petersen, S. E., Belle, E. V., Townsend, N. P., Conrad, N., Kaplon-Cieslicka, A., Kazakiewicz, D., Kavousi, M., Cvijić, M., Ignatiuk, B., et al. (2017) · European Heart Journal · doi:10.1093/eurheartj/ehag345 · Cited by 964 · see citing works
Global and Regional Patterns in Cardiovascular Mortality From 1990 to 2013
Roth, G. A., Huffman, M. D., Moran, A. E., Feigin, V. L., Mensah, G. A., Naghavi, M., & Murray, C. J. L. (2015) · Circulation · doi:10.1161/circulationaha.114.008720 · Cited by 883 · see citing works
Self-citationCardiovascular Effects and Benefits of Exercise
Nystoriak, M. A., & Bhatnagar, A. (2018) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2018.00135 · Cited by 881 · see citing works
Epidemiology of Diabetes Mellitus and Cardiovascular Disease
Glovaci, D., Fan, W., & Wong, N. D. (2019) · Current Cardiology Reports · doi:10.1007/s11886-019-1107-y · Cited by 764 · see citing works
Peker, Y., Glantz, H., Eulenburg, C., Wegscheider, K., Herlitz, J., & Thunström, E. (2016) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201601-0088oc · Cited by 756 · see citing works
Global Overview of the Epidemiology of Atherosclerotic Cardiovascular Disease
Barquera, S., Pedroza-Tobías, A., Medina, C., Hernández-Barrera, L., Bibbins-Domingo, K. B., Lozano, R., & Moran, A. E. (2015) · Archives of Medical Research · doi:10.1016/j.arcmed.2015.06.006 · Cited by 715 · see citing works
Self-citationPopulation ageing and mortality during 1990–2017: A global decomposition analysis
Cheng, X., Yang, Y., Schwebel, D. C., Liu, Z., Li, L., Cheng, P., Ning, P., & Hu, G. (2020) · PLoS Medicine · doi:10.1371/journal.pmed.1003138 · Cited by 535 · see citing works
Homocysteine lowering interventions for preventing cardiovascular events
Martí-Carvajal, A. J., Solà, I., Lathyris, D., & Salanti, G. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006612.pub2 · Cited by 520 · see citing works
Global epidemiology and future trends of heart failure
Lippi, G., & Sanchis‐Gomar, F. (2020) · AME Medical Journal · doi:10.21037/amj.2020.03.03 · Cited by 507 · see citing works
2016 European Guidelines on cardiovascular disease prevention in clinical practice
Piepoli, M. F., Hoes, A. W., Agewall, S., Albus, C., Brotons, C., Catapano, A. L., Cooney, M. T., Corrà, U., Cosyns, B., Deaton, C., et al. (2016) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2016.05.037 · Cited by 488 · see citing works
GLP-1 Receptor Agonists: Beyond Their Pancreatic Effects
Zhao, X., Wang, M., Wen, Z., Lu, Z., Cui, L., Fu, C., Xue, H., Liu, Y., & Zhang, Y. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.721135 · Cited by 463 · see citing works
Global Atlas of Cardiovascular Disease 2000-2016: The Path to Prevention and Control
Thomas, H., Diamond, J. E., Vieco, A., Chaudhuri, S., Shinnar, E., CROMER, S. J., Perel, P., Mensah, G. A., Narula, J., Johnson, C. O., et al. (2018) · Global Heart · doi:10.1016/j.gheart.2018.09.511 · Cited by 440 · see citing works
Self-citationBlood-Pressure and Cholesterol Lowering in Persons without Cardiovascular Disease
Yusuf, S., Lonn, E., Pais, P. S., Bosch, J., López-Jaramillo, P. A., Zhu, J., Xavier, D., Avezum, Á., Leiter, L. A., Piegas, L. S., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1600177 · Cited by 373 · see citing works
Emerging Role of Precision Medicine in Cardiovascular Disease
Leopold, J. A., & Loscalzo, J. (2018) · Circulation Research · doi:10.1161/circresaha.117.310782 · Cited by 373 · see citing works
Cardiovascular Health in Brazil
Ribeiro, A. L. P., Duncan, B. B., Brant, L. C. C., Lotufo, P. A., Mill, J. G., & Barreto, S. M. (2016) · Circulation · doi:10.1161/circulationaha.114.008727 · Cited by 359 · see citing works
Normalization of NAD + Redox Balance as a Therapy for Heart Failure
Lee, C. F., Chavez, J. D., Garcia‐Menendez, L., Choi, Y. S., Roe, N. D., Chiao, Y. A., Edgar, J. S., Goo, Y. A., Goodlett, D. R., Bruce, J. E., et al. (2016) · Circulation · doi:10.1161/circulationaha.116.022495 · Cited by 337 · see citing works
Mensah, G., Roth, G., Sampson, U. K. A., Moran, A., Feigin, V. L., Forouzanfar, M., Naghavi, M., & Cjl, M. (2015) · Cardiovascular journal of South Africa/Cardiovascular journal of Southern Africa · doi:10.5830/cvja-2015-036 · Cited by 336 · see citing works
Self-citationon behalf of the China Kadoorie Biobank Collaborative Group, Sun, L., Clarke, R., Bennett, D., Yu, C., Walters, R. G., Hill, M., Parish, S., Millwood, I. Y., Bian, Z., et al. (2019) · Nature Medicine · doi:10.1038/s41591-019-0366-x · Cited by 316 · see citing works
Fifteen new risk loci for coronary artery disease highlight arterial-wall-specific mechanisms
CARDIoGRAMplusC4D, Howson, J. M. M., EPIC-CVD, Zhao, W., Barnes, D. R., Ho, W.-K., Young, R., Paul, D. S., Waite, L. L., Freitag, D. F., et al. (2017) · Nature Genetics · doi:10.1038/ng.3874 · Cited by 304 · see citing works
Periodontitis and Cardiovascular Diseases. Consensus Report
Sanz, M., Castillo, A. M. D., Jepsen, S. V., González‐Juanatey, J. R., D’Aiuto, F., Bouchard, P., Chapple, I., Dietrich, T., Gotsman, I., Graziani, F., et al. (2020) · Global Heart · doi:10.5334/gh.400 · Cited by 284 · see citing works
Apolipoprotein B and Cardiovascular Disease: Biomarker and Potential Therapeutic Target
Behbodikhah, J., Ahmed, S., Elyasi, A., Kasselman, L. J., Leon, J. D., Glass, A. D., & Reiss, A. B. (2021) · Metabolites · doi:10.3390/metabo11100690 · Cited by 284 · see citing works
Homocysteine-lowering interventions for preventing cardiovascular events
Martí-Carvajal, A. J., Solà, I., Lathyris, D., & Dayer, M. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006612.pub5 · Cited by 284 · see citing works
Bollyky, T. J., Templin, T., Cohen, M., & Dieleman, J. L. (2017) · Health Affairs · doi:10.1377/hlthaff.2017.0708 · Cited by 282 · see citing works
Epidemiology, Pathophysiology, and Prognosis of Heart Failure in Older Adults
Dharmarajan, K., & Rich, M. W. (2017) · Heart Failure Clinics · doi:10.1016/j.hfc.2017.02.001 · Cited by 277 · see citing works
Fiolet, A. T. L., Opstal, T. S. J., Mosterd, A., Eikelboom, J. W., Jolly, S. S., KEECH, A. C., Kelly, P. J., Tong, D. C., Layland, J. J., Nidorf, S. M., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab115 · Cited by 259 · see citing works
Resistance Exercise Training as a Primary Countermeasure to Age-Related Chronic Disease
Mcleod, J. C., Stokes, T., & Phillips, S. M. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2019.00645 · Cited by 254 · see citing works
Yan, T., Zhu, S., Yin, X., Xie, C., Xue, J., Zhu, M., Weng, F., Zhu, S., Xiang, B., Zhou, X., et al. (2023) · Journal of the American Heart Association · doi:10.1161/jaha.122.027852 · Cited by 253 · see citing works
Prevention of stroke: a strategic global imperative
Feigin, V. L., Norrving, B., George, M. G., Foltz, J. L., Roth, G. A., & Mensah, G. A. (2016) · Nature Reviews Neurology · doi:10.1038/nrneurol.2016.107 · Cited by 250 · see citing works
Self-citationPeptides as Therapeutic Agents: Challenges and Opportunities in the Green Transition Era
Rossino, G., Marchese, E., Galli, G., Verde, F., Finizio, M., Serra, M., Linciano, P., & Collina, S. (2023) · Molecules · doi:10.3390/molecules28207165 · Cited by 245 · see citing works
Mentkowski, K. I., & Lang, J. K. (2019) · Scientific Reports · doi:10.1038/s41598-019-46407-1 · Cited by 244 · see citing works
Cardiometabolic-Based Chronic Disease, Adiposity and Dysglycemia Drivers
Mechanick, J. I., Farkouh, M. E., Newman, J. D., & Garvey, W. T. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.11.044 · Cited by 243 · see citing works
Epidemiology in diabetes mellitus and cardiovascular disease
Fan, W. (2017) · Cardiovascular Endocrinology · doi:10.1097/xce.0000000000000116 · Cited by 242 · see citing works
Jung, S., Hwang, B., Shin, S. Y., Park, E., Park, S., Kim, C. W., Kim, E., Choo, E. H., Choi, I. J., Świrski, F. K., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-32284-2 · Cited by 213 · see citing works
Rosoff, D. B., Smith, G. D., Mehta, N. N., Clarke, T., & Lohoff, F. W. (2020) · PLoS Medicine · doi:10.1371/journal.pmed.1003410 · Cited by 208 · see citing works
Unmet Need for Adjunctive Dyslipidemia Therapy in Hypertriglyceridemia Management
Ganda, O. P., Bhatt, D. L., Mason, R. P., Miller, M., & Boden, W. E. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.04.061 · Cited by 195 · see citing works
Won, K., Park, E. J., Han, D., Lee, J. H., Choi, S., Chun, E. J., Park, S. H., Han, H., Sung, J., Jung, H. O., et al. (2020) · Cardiovascular Diabetology · doi:10.1186/s12933-020-01008-5 · Cited by 193 · see citing works
Localization of fat depots and cardiovascular risk
Gruzdeva, O. V., Borodkinа, D. A., Учасова, Е. Г., Dyleva, Y. A., & Барбараш, О. Л. (2018) · Lipids in Health and Disease · doi:10.1186/s12944-018-0856-8 · Cited by 185 · see citing works
Influenza Vaccine in Heart Failure
Modin, D., Jørgensen, M. E., Gislason, G., Jensen, J. S., Køber, L., Claggett, B. L., Hegde, S. M., Solomon, S. D., Torp-Pedersen, C. T., & Biering‐Sørensen, T. (2019) · Circulation · doi:10.1161/circulationaha.118.036788 · Cited by 173 · see citing works
Photoplethysmography and Deep Learning: Enhancing Hypertension Risk Stratification
Liang, Y., Chen, Z., Ward, R. K., & Elgendi, M. (2018) · Biosensors · doi:10.3390/bios8040101 · Cited by 170 · see citing works
DeFilippis, A. P., Young, R. L., McEvoy, J. W., Michos, E. D., Sandfort, V., Kronmal, R. A., McClelland, R. L., & Blaha, M. J. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw301 · Cited by 169 · see citing works
Comprehensive Metabolomic Profiling and Incident Cardiovascular Disease: A Systematic Review
Ruiz‐Canela, M., Hruby, A., Clish, C. B., Liang, L., Martínez‐González, M. Á., & Hu, F. B. (2017) · Journal of the American Heart Association · doi:10.1161/jaha.117.005705 · Cited by 165 · see citing works
Prabhakaran, D., Anand, S., Watkins, D., Gaziano, T., Wu, Y., Mbanya, J. C., Nugent, R., Ajay, V. S., Afshin, A., Adler, A., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(17)32471-6 · Cited by 162 · see citing works
Self-citationF. Piepoli, M. (2017) · International Journal of Behavioral Medicine · doi:10.1007/s12529-016-9583-6 · Cited by 162 · see citing works
Zhu, W., Buffa, J. A., Wang, Z., Warrier, M., Schugar, R., Shih, D. M., Gupta, N., Gregory, J. C., Org, E., Fu, X., et al. (2018) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.14234 · Cited by 161 · see citing works
Bloomfield, H. E., Koeller, E., Greer, N., MacDonald, R., Kane, R., & Wilt, T. J. (2016) · Annals of Internal Medicine · doi:10.7326/m16-0361 · Cited by 159 · see citing works
Resource Effective Strategies to Prevent and Treat Cardiovascular Disease
Schwalm, J.-D., McKee, M., Huffman, M. D., & Yusuf, S. (2016) · Circulation · doi:10.1161/circulationaha.115.008721 · Cited by 152 · see citing works
The gut microbiota: An emerging risk factor for cardiovascular and cerebrovascular disease
Ascher, S., & Reinhardt, C. (2017) · European Journal of Immunology · doi:10.1002/eji.201646879 · Cited by 150 · see citing works
Effects of Interleukin 17 on the cardiovascular system
Robert, M., & Miossec, P. (2017) · Autoimmunity Reviews · doi:10.1016/j.autrev.2017.07.009 · Cited by 146 · see citing works
2016 European Guidelines on cardiovascular disease prevention in clinical practice
Piepoli, M. F., Hoes, A. W., Agewall, S., Albus, C., Brotons, C., Catapano, A. L., Cooney, M. T., Corrà, U., Cosyns, B., Deaton, C., et al. (2016) · Kardiologia Polska · doi:10.5603/kp.2016.0120 · Cited by 143 · see citing works
Global trend of diabetes mortality attributed to vascular complications, 2000–2016
Ling, W., Huang, Y., Huang, Y., Fan, R., Sui, Y., & Zhao, H.-L. (2020) · Cardiovascular Diabetology · doi:10.1186/s12933-020-01159-5 · Cited by 141 · see citing works
Kim, A. S., Cahill, E. A., & Cheng, N. T. (2015) · Stroke · doi:10.1161/strokeaha.115.008226 · Cited by 140 · see citing works
Periodontal Health and Disease in the Context of Systemic Diseases
Isola, G., Santonocito, S., Lupi, S. M., Polizzi, A., Sclafani, R., Patini, R., & Marchetti, E. (2023) · Mediators of Inflammation · doi:10.1155/2023/9720947 · Cited by 140 · see citing works
Michel Komajda, N., Böhm, M., BORER, J. S., Ford, I., Tavazzi, L., Pannaux, M., & Swedberg, K. B. (2018) · European Journal of Heart Failure · doi:10.1002/ejhf.1234 · Cited by 140 · see citing works
Hirata, T., Arai, Y., Yuasa, S., Abe, Y., Takayama, M., Sasaki, T., Kunitomi, A., Inagaki, H., Endo, M., Morinaga, J., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-17636-0 · Cited by 138 · see citing works
A general strategy of 3D printing thermosets for diverse applications
Lei, D., Yang, Y., Liu, Z., Chen, S., Song, B., Shen, A., Yang, B., Li, S., Yuan, Z., Qi, Q., et al. (2018) · Materials Horizons · doi:10.1039/c8mh00937f · Cited by 136 · see citing works
Chavez, J. D., Lee, C. F., Caudal, A., Keller, A., Tian, R., & Bruce, J. E. (2017) · Cell Systems · doi:10.1016/j.cels.2017.10.017 · Cited by 135 · see citing works
Guía ESC 2021 sobre el diagnóstico y tratamiento de la insuficiencia cardiaca aguda y crónica
McDonagh, T. A., Metra, M., Adamo, M., Gardner, R. S., Baumbach, A., Böhm, M., Burri, H., Butler, J., Čelutkienė, J., Chioncel, O. D., et al. (2022) · Revista Española de Cardiología · doi:10.1016/j.recesp.2021.11.027 · Cited by 132 · see citing works
Limberg, J. K., Casey, D. P., Trinity, J. D., Nicholson, W. T., Wray, D. W., Tschakovsky, M. E., GREEN, D. J., Hellsten, Y., Fadel, P. J., Joyner, M. J., et al. (2019) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00649.2019 · Cited by 130 · see citing works
Sinha, S. S., Sjoding, M. W., Sukul, D., Prescott, H. C., Iwashyna, T. J., Gurm, H. S., Cooke, C. R., & Nallamothu, B. K. (2017) · Circulation Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.117.003616 · Cited by 127 · see citing works
Mendelian Randomization Study of PCSK9 and HMG-CoA Reductase Inhibition and Cognitive Function
Rosoff, D. B., Bell, A. S., Jung, J., Wagner, J., Mavromatis, L. A., & Lohoff, F. W. (2022) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2022.05.041 · Cited by 126 · see citing works
Roles of Phenolic Compounds in the Reduction of Risk Factors of Cardiovascular Diseases
Mariane Lutz, R., Eduardo Fuentes, Q., Ávila, F., Alarcón, M. A., & Palomo, I. F. (2019) · Molecules · doi:10.3390/molecules24020366 · Cited by 126 · see citing works
Rasmussen, K. L. (2016) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2016.10.037 · Cited by 125 · see citing works
Biomimetic nanoparticle technology for cardiovascular disease detection and treatment
Park, J. H., Dehaini, D., Zhou, J., Holay, M., Fang, R. H., & Zhang, L. (2019) · Nanoscale Horizons · doi:10.1039/c9nh00291j · Cited by 124 · see citing works
Mobile Phone Interventions for the Secondary Prevention of Cardiovascular Disease
Park, L. G., Beatty, A. L., Stafford, Z., & Whooley, M. (2016) · Progress in cardiovascular diseases · doi:10.1016/j.pcad.2016.03.002 · Cited by 126 · see citing works
Impact of Aging on Cardiovascular Diseases
Zhao, D. H., Wang, Y., Wong, N. D., & Wang, J. (2024) · JACC Asia · doi:10.1016/j.jacasi.2024.02.002 · Cited by 123 · see citing works
The High Cost of Stroke and Stroke Cytoprotection Research
Lapchak, P. A., & Zhang, J. H. (2016) · Translational Stroke Research · doi:10.1007/s12975-016-0518-y · Cited by 122 · see citing works
Renin angiotensin aldosterone inhibition in the treatment of cardiovascular disease
Ferrario, C. M., & Mullick, A. E. (2017) · Pharmacological Research · doi:10.1016/j.phrs.2017.05.020 · Cited by 121 · see citing works
Modeling Future Cardiovascular Disease Mortality in the United States
Pearson‐Stuttard, J., Guzman-Castillo, M., Peñalvo, J. L., Rehm, C. D., Afshin, A., Danaei, G., Kypridemos, C., Gaziano, T., Mozaffarian, D., Capewell, S., et al. (2016) · Circulation · doi:10.1161/circulationaha.115.019904 · Cited by 121 · see citing works
Indian guidelines on hypertension-IV (2019)
Shah, S. N., Munjal, Y. P., Kamath, S. A., Wander, G. S., Mehta, N., Mukherjee, S., Kirpalani, A. L., Gupta, P., Shah, H., Rohatgi, R., et al. (2020) · Journal of Human Hypertension · doi:10.1038/s41371-020-0349-x · Cited by 120 · see citing works
Adherence to the Mediterranean diet and risk of stroke and stroke subtypes
Chen, G., Neelakantan, N., Martín‐Calvo, N., Koh, W., Yuan, J., Bonaccio, M., Iacoviello, L., Martínez‐González, M. Á., Qin, L., & van Dam, R. M. (2019) · European Journal of Epidemiology · doi:10.1007/s10654-019-00504-7 · Cited by 119 · see citing works
Cardiovascular disease (CVD): assessment, prediction and policy implications
Rehman, S., Rehman, E., Ikram, M., & Jianglin, Z. (2021) · BMC Public Health · doi:10.1186/s12889-021-11334-2 · Cited by 118 · see citing works
Chan, N., & Weitz, J. I. (2019) · Circulation Research · doi:10.1161/circresaha.118.313155 · Cited by 116 · see citing works
Oral Microbiota: A Major Player in the Diagnosis of Systemic Diseases
Thomas, C., Minty, M., Vinel, A., Canceill, T., Loubières, P., Burcelin, R., Kaddech, M., Blasco‐Baqué, V., & Laurencin‐Dalicieux, S. (2021) · Diagnostics · doi:10.3390/diagnostics11081376 · Cited by 116 · see citing works
Chen, H., Li, M., Liu, L., Dang, X., Zhu, D., & Tian, G. (2019) · Medicine · doi:10.1097/md.0000000000016267 · Cited by 115 · see citing works
Hambleton, I. R., Caixeta, R. D. B., Jeyaseelan, S. M., Luciani, S., & Hennis, A. J. M. (2023) · The Lancet Regional Health - Americas · doi:10.1016/j.lana.2023.100483 · Cited by 114 · see citing works
A physiological characterization of the Cafeteria diet model of metabolic syndrome in the rat
Gomez-Smith, M., Karthikeyan, S., Jeffers, M. S., Janik, R., Thomason, L. A. M., Stefanovic, B., & Corbett, D. (2016) · Physiology & Behavior · doi:10.1016/j.physbeh.2016.09.029 · Cited by 112 · see citing works
Ma, Q., Fan, Q., Han, X., Dong, Z., Xu, J., Bai, J., Tao, W., Sun, D., & Wang, C. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.11.064 · Cited by 112 · see citing works
Fixed-dose combination therapy for the prevention of atherosclerotic cardiovascular diseases
Bahiru, E. M., de Cates, A. N., Farr, M. R. B., Jarvis, M. C., Palla, M., Rees, K., Ebrahim, S. B. J., & Huffman, M. D. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009868.pub3 · Cited by 110 · see citing works
Ezetimibe for the prevention of cardiovascular disease and all-cause mortality events
Zhan, S., Tang, M., Liu, F., Xia, P., Shu, M., & Wu, X. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012502.pub2 · Cited by 109 · see citing works
Small-diameter hybrid vascular grafts composed of polycaprolactone and polydioxanone fibers
Pan, Y., Zhou, X., Wei, Y., Zhang, Q., Wang, T., Zhu, M., Li, W., Huang, R., Liu, R., Chen, J., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-03851-1 · Cited by 108 · see citing works
- Authors
- Roth, G. A., Forouzanfar, M. H., Moran, A. E., Barber, R., Nguyen, G., Feigin, V. L., Naghavi, M., Mensah, G. A., & Murray, C. J. L.
- Affiliations
- National Institutes of Health (US)
- University of Washington (US)
- Columbia University (US)
- Auckland University of Technology (NZ)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2015-04-02
- Volume
- 372
- Issue
- 14
- Pages
- 1333-1341
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- PMC
- PMC4482354
- OpenAlex
- W1986019364
- Semantic Scholar
- 27a6b9a739f391969318dbfd3ffe6b84aa566d21
- Cited by
- 1,188
- References
- 14
- Citations by year
- 2026: 30 · 2025: 87 · 2024: 115 · 2023: 110 · 2022: 117 · 2021: 123 · 2020: 141 · 2019: 118 · 2018: 105 · 2017: 110 · 2016: 98 · 2015: 31
- FWCI
- 89.97
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Heart, Lung, and Blood Institute (K08HL089675)
- Topics
- Health Sciences › Medicine › Epidemiology › Healthcare Systems and Public Health
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Risk Factors
- Social Sciences › Demography › Insurance, Mortality, Demography, Risk Management
- Keywords
- cardiovascular mortality, population aging, population growth, age-specific mortality, counterfactual scenarios, GDP per capita, global health trends, regional variation in mortality
- MeSH terms
- Age Factors, Cardiovascular Diseases, Demography, Humans, Income, Mortality, Sex Factors, Global Health
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-04.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-04.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review